Home > Income Statement > BIOCON

BIOCON
Consolidated Net Profit

    Back to Income Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹386 Cr₹1,013 Cr₹1,023 Cr₹463 Cr₹648 Cr

What is the latest Consolidated Net Profit of BIOCON ?

The latest Consolidated Net Profit ratio of BIOCON is ₹386 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹386 Cr
Mar2025₹1,013 Cr
Mar2024₹1,023 Cr
Mar2023₹463 Cr
Mar2022₹648 Cr

How is Consolidated Net Profit of BIOCON Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹386 Cr
-61.95
Mar2025 ₹1,013 Cr
-0.90
Mar2024 ₹1,023 Cr
120.99
Mar2023 ₹463 Cr
-28.64
Mar2022 ₹648 Cr -

Compare Consolidated Net Profit of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹58,750.7 Cr -2.8% -9.3% 8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,861.0 Cr -2% -6.1% 12.9% Stock Analytics
DIVIS LABORATORIES ₹254,319.0 Cr 3.2% 5.3% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,153.0 Cr -1.9% -2.9% 32.7% Stock Analytics
CIPLA ₹107,406.0 Cr -1.5% -4% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,362.0 Cr -2.7% 4.2% -1.2% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-2.8%

-9.3%

8.1%

SENSEX

0.2%

-4.6%

-9.6%


You may also like the below Video Courses